|
|
Volumn 86, Issue 2, 2008, Pages 204-205
|
|
Anti-human leukocyte antigen antibodies after islet transplantation: What do they really mean?
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BASILIXIMAB;
CALCINEURIN INHIBITOR;
HLA ANTIBODY;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
RAPAMYCIN;
STEROID;
TACROLIMUS;
THYMOCYTE ANTIBODY;
ANTIBODY;
HLA ANTIGEN;
IMMUNOSUPPRESSIVE AGENT;
INSULIN;
ALLOTRANSPLANTATION;
GRAFT RECIPIENT;
GRAFT REJECTION;
GRAFT SURVIVAL;
HUMAN;
IMMUNIZATION;
IMMUNOSUPPRESSIVE TREATMENT;
INSULIN DEPENDENT DIABETES MELLITUS;
KIDNEY GRAFT;
KIDNEY TRANSPLANTATION;
NOTE;
ORGAN DONOR;
OUTCOME ASSESSMENT;
PANCREAS ISLET TRANSPLANTATION;
PRIORITY JOURNAL;
SCREENING;
SENSITIZATION;
CHEMISTRY;
CLINICAL TRIAL;
COHORT ANALYSIS;
CYTOLOGY;
DIABETES MELLITUS;
IMMUNOLOGY;
IMMUNOPHENOTYPING;
METABOLISM;
METHODOLOGY;
PANCREAS ISLET;
ANTIBODIES;
CLINICAL TRIALS AS TOPIC;
COHORT STUDIES;
DIABETES MELLITUS;
HLA ANTIGENS;
HUMANS;
IMMUNOPHENOTYPING;
IMMUNOSUPPRESSIVE AGENTS;
INSULIN;
ISLETS OF LANGERHANS;
ISLETS OF LANGERHANS TRANSPLANTATION;
|
|
EID: 49249084635
PISSN: 00411337
EISSN: None
Source Type: Journal
DOI: 10.1097/TP.0b013e31817ba6e5 Document Type: Note |
|
Times cited : (3)
|
|
References (5)
|
